Business Context and Reporting Period
Company: Indigo Acquisition Corp. (Indigo)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Indigo is a Cayman Islands exempted company formed as a Special Purpose Acquisition Company (SPAC) with no operating history. Its sole purpose is to effect a merger, share exchange, asset acquisition, or similar business combination with one or more target businesses. The Company consummated its Initial Public Offering (IPO) on July 2, 2025, and fully exercised the underwriters' over-allotment option on July 11, 2025.
Deadline: The Company must complete an initial business combination by April 2, 2027, or it will be required to liquidate.
Key Financial Metrics
| Metric | Value (as of Dec 31, 2025) |
|---|---|
| Net Income | $1,822,212 |
| Operating Costs | $367,996 (Formation and operating costs) |
| Interest Income | $2,298,371 (Earned on Trust Account) |
| Trust Account Balance | $117,298,371 (Marketable securities) |
| Cash (Outside Trust) | $666,920 |
| Total Assets | $118,083,962 |
| Total Liabilities | $4,109,042 (Includes $4,025,000 deferred underwriting fee) |
| Shares Outstanding | 14,755,000 Ordinary Shares (11,500,000 Public Shares subject to redemption) |
| Redemption Value per Share | Approx. $10.20 |
Material Changes vs. Prior Period
- Capitalization: The Company transitioned from a pre-IPO entity with minimal assets ($2,263 total assets in 2024) to a publicly traded SPAC with $118 million in total assets following the July 2025 IPO and over-allotment exercise.
- Profitability: The Company reported a net loss of $18,682 for the period from inception (June 7, 2024) through December 31, 2024. For the full year ended December 31, 2025, the Company reported a net income of $1,822,212, driven primarily by $2.3 million in interest income from the Trust Account.
- Liquidity: Cash held outside the Trust Account increased from $0 to $666,920 to fund working capital and search activities.
- Liabilities: A deferred underwriting fee of $4,025,000 was recorded upon the completion of the IPO, representing a significant new liability not present in the prior period.
Guidance, Outlook, Risks, and Contingencies
Outlook and Guidance: Management intends to complete an initial business combination using cash from the Trust Account, private financings, or equity. No specific financial guidance or target identification has been provided. The Company expects to incur significant costs in pursuing acquisition plans.
Going Concern: The filing explicitly states there is substantial doubt about the Company's ability to continue as a going concern. The Company has limited liquidity outside the Trust Account and requires additional capital to sustain operations until the April 2, 2027 deadline. If a business combination is not consummated by this date, the Company will liquidate.
Key Risks:
- Liquidation Risk: Failure to complete a business combination by April 2, 2027, will result in mandatory liquidation and dissolution.
- Trust Account Claims: Third-party claims (e.g., from vendors or target businesses) could reduce the Trust Account balance below $10.00 per share, although the Sponsor has agreed to indemnify the Company against such claims (subject to limitations).
- Redemption Risk: A large number of shareholders may redeem their shares, potentially reducing the cash available for the transaction or forcing the Company to seek additional financing.
- Investment Company Act: There is a risk the Company could be deemed an unregistered investment company if it does not strictly adhere to investment restrictions, which could force liquidation.
Investor Verification Checklist
- Verify the current balance of the Trust Account and the per-share redemption value, noting that interest income is subject to taxation.
- Confirm the Sponsor's financial ability to satisfy indemnification obligations if third-party claims reduce the Trust Account below $10.00 per share.
- Monitor the Company's cash burn rate outside the Trust Account to assess the likelihood of needing additional working capital loans before the April 2027 deadline.
- Review the terms of the deferred underwriting fee ($4,025,000) and its impact on post-combination capital structure.
- Check for any updates regarding the selection of a target business or extension of the combination deadline.